People

Name Kožíšek Milan
Position Scientist

 

Milan Kožíšek

Milan Kožíšek, Ph.D.

Scientist


Proteases of Human Pathogens
Institute of Organic Chemistry and Biochemistry ASCR, v.v.i.
Flemingovo nam. 2, CZ-166 10 Prague 6, Czech Republic

Phone: (+420) 220 183 518
Fax: (+420) 220 183 578

 

 
Education
2006-2010 Ph.D. in biochemistry, Faculty of Science, Charles University, Prague, Czech Republic.
Ph.D. thesis "Overcoming drug resistance: The discovery, design and characterization of new nonpeptidic inhibitors of HIV-1 protease" under supervision of Dr. Jan Konvalinka at the Institute of OrganicChemistry and Biochemistry AS CR, Prague.
1998-2003 M.Sc. in biochemistry at the Faculty of Science, Charles University, Prague, Czech Republic.
Diploma thesis: "The viral resistance in HIV positive patiens treated with inhibitors of HIV protease" under supervision of Dr. J.Konvalinka at the Institute of Organic Chemistry and Biochemistry ASCR, Prague.
 
Appointments
since 2010 Postdoctoral fellow in Jan Konvalinka's laboratory.
 
Awards
2011 The Josef Hlávka Prize for year 2011.
2008 Chairman´s award for the best poster "Kinetic, Structural and Thermodynamic Characterization of HIV Protease with Insertion in the Flap Region Isolated from and HIV-Positive Patient" at the conference Applications of Biocalorimetry (abc6), Heidelberg, Germany.
2006 Chairman´s award for the best poster "Metallacarboranes as Specific and Potent Inhibitors of HIV Protease and its Resistant Mutants" at the conference HIV DART 2006: Frontiers in Drug Development for Antiretroviral Therapies, Cancun, Mexico.
 
Patents and Inventions
Král V., Cígler P., Konvalinka J., Kožíšek M., Pokorná J., Prejdová J., Lepšík M., Grüner B., Plešek J., Kraeuslich H.-G., Bodem J.:
Novel HIV protease inhibitors.
Mezinárodní patent WO/2005/073240.


Král V., Cígler P., Konvalinka J., Kožíšek M., Pokorná, J., Prejdová J., Lepšík M., Grüner B., Plešek J., Kraeuslich H.-G., Bodem J.:
Novel inhibitors of HIV protease.
Český patent CZ 295245.

 
Research interests
  • HIV drug development focusing on HIV protease and viral assembly
  • ultrasensitive microcalorimetry in the study of biomolecular interactions and protein stability
  • drug development targeting neuraminidase from the Influenza virus